Ole Geir Solberg

  • Consultant interventional cardiologist; MD, PhD
 

Publications 2024

Røsjø H, Solberg OG, Aaberge L, Bosse G, Omland T, Stavem K, Myhre PL (2024)
Trans-cardiac gradient of secretoneurin in patients with Takotsubo syndrome
Cardiology (in press)
DOI 10.1159/000539094, PubMed 38663366

Solberg OG (2024)
ESCHF-23-00103R1 'Microvascular function and inflammatory activation in Takotsubo cardiomyopathy'
ESC Heart Fail, 11 (2), 1279
DOI 10.1002/ehf2.14652, PubMed 38164054

Publications 2023

Arora S, Zimmermann FM, Solberg OG, Nytrøen K, Aaberge L, Okada K, Ahn JM, Honda Y, Khush KK, Angeras O, Karason K, Gullestad L, Fearon WF (2023)
Prognostic value of intravascular ultrasound early after heart transplantation
Eur Heart J, 44 (48), 5160-5162
DOI 10.1093/eurheartj/ehad648, PubMed 37850514

Bekkenes ME, Fagerland MW, Solberg OG, Aaberge L, Klingenberg O, Norseth J, Rosseland LA (2023)
Reply to: exploring cardiac effects after oxytocin 2.5 IU or carbetocin 100 μg - a randomised controlled trial in women undergoing planned caesarean delivery
Eur J Anaesthesiol, 40 (6), 453-454
DOI 10.1097/EJA.0000000000001841, PubMed 37132304

Rafique M, Solberg OG, Gullestad L, Bendz B, Murbræch K, Nytrøen K, Rolid K, Lunde K (2023)
Effects of high-intensity interval training on cardiac remodelling, function and coronary microcirculation in de novo heart transplant patients: a substudy of the HITTS randomised controlled trial
BMJ Open Sport Exerc Med, 9 (3), e001331
DOI 10.1136/bmjsem-2022-001331, PubMed 37440977

Solberg OG, Aaberge L, Bosse G, Ueland T, Gullestad L, Aukrust P, Stavem K (2023)
Microvascular function and inflammatory activation in Takotsubo cardiomyopathy
ESC Heart Fail, 10 (5), 3216-3222
DOI 10.1002/ehf2.14461, PubMed 37537779

Publications 2022

Bekkenes ME, Fagerland MW, Solberg OG, Aaberge L, Klingenberg O, Norseth J, Rosseland LA (2022)
Exploring cardiac effects after oxytocin 2.5 IU or carbetocin 100 μg: A randomised controlled trial in women undergoing planned caesarean delivery
Eur J Anaesthesiol, 39 (12), 928-938
DOI 10.1097/EJA.0000000000001763, PubMed 36239406

Publications 2021

Ahn JM, Zimmermann FM, Arora S, Solberg OG, Angerås O, Rolid K, Rafique M, Aaberge L, Karason K, Okada K, Luikart H, Khush KK, Honda Y, Pijls NHJ, Lee SE, Kim JJ, Park SJ, Gullestad L, Fearon WF (2021)
Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation
Eur Heart J, 42 (48), 4918-4929
DOI 10.1093/eurheartj/ehab568, PubMed 34665224

Ahn JM, Zimmermann FM, Gullestad L, Angerås O, Karason K, Russell K, Lunde K, Okada K, Luikart H, Khush KK, Honda Y, Pijls NHJ, Lee SE, Kim JJ, Park SJ, Solberg OG, Fearon WF (2021)
Microcirculatory Resistance Predicts Allograft Rejection and Cardiac Events After Heart Transplantation
J Am Coll Cardiol, 78 (24), 2425-2435
DOI 10.1016/j.jacc.2021.10.009, PubMed 34886963

Bekkenes M, Jørgensen MM, Flem Jacobsen A, Wang Fagerland M, Rakstad-Larsen H, Solberg OG, Aaberge L, Klingenberg O, Steinsvik T, Rosseland LA (2021)
A study protocol for the cardiac effects of a single dose of either oxytocin 2.5 IU or carbetocin 100 µg after caesarean delivery: a prospective randomized controlled multi-centre trial in Norway
F1000Res, 10, 973
DOI 10.12688/f1000research.73112.2, PubMed 34745566

Rafique M, Solberg OG, Gullestad L, Bendz B, Holm NR, Neghabat O, Dijkstra J, Nytrøen K, Rolid K, Lunde K (2021)
A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy
Clin Transplant, 36 (1), e14488
DOI 10.1111/ctr.14488, PubMed 34747048

Publications 2020

Arain F, Abraityte A, Bogdanova M, Solberg OG, Michelsen AE, Lekva T, Aakhus S, Holm S, Halvorsen B, Finsen AV, Vinge LE, Nymo S, Espeland T, Ranheim T, Aukrust P, Vaage IJ, Auensen A, Gullestad L, Ueland T (2020)
YKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic Stenosis
Circ Heart Fail, 13 (10), e006643
DOI 10.1161/CIRCHEARTFAILURE.119.006643, PubMed 32962417

Kummen M, Solberg OG, Storm-Larsen C, Holm K, Ragnarsson A, Trøseid M, Vestad B, Skårdal R, Yndestad A, Ueland T, Svardal A, Berge RK, Seljeflot I, Gullestad L, Karlsen TH, Aaberge L, Aukrust P, Hov JR (2020)
Rosuvastatin alters the genetic composition of the human gut microbiome
Sci Rep, 10 (1), 5397
DOI 10.1038/s41598-020-62261-y, PubMed 32214138

Publications 2019

Solberg OG, Stavem K, Ragnarsson A, Beitnes JO, Skårdal R, Seljeflot I, Ueland T, Aukrust P, Gullestad L, Aaberge L (2019)
Index of microvascular resistance to assess the effect of rosuvastatin on microvascular function in women with chest pain and no obstructive coronary artery disease: A double-blind randomized study
Catheter Cardiovasc Interv, 94 (5), 660-668
DOI 10.1002/ccd.28157, PubMed 30790446

Publications 2018

Dalbak LG, Schirmer H, Straand J, Mdala I, Solberg OG, Melbye H (2018)
Impaired left ventricular filling is associated with decreased pulse oximetry values
Scand Cardiovasc J, 52 (4), 211-217
DOI 10.1080/14017431.2018.1464662, PubMed 29671629

Publications 2016

Solberg OG, Stavem K, Ragnarsson A, Ioanes D, Arora S, Endresen K, Benth JŠ, Gullestad L, Gude E, Andreassen AK, Aaberge L (2016)
Index of microvascular resistance after early conversion from calcineurin inhibitor to everolimus in heart transplantation: A sub-study to a 1-year randomized trial
J Heart Lung Transplant, 35 (8), 1010-7
DOI 10.1016/j.healun.2016.03.002, PubMed 27113960

Publications 2015

Arora S, Andreassen AK, Andersson B, Gustafsson F, Eiskjaer H, Bøtker HE, Rådegran G, Gude E, Ioanes D, Solbu D, Sigurdardottir V, Dellgren G, Erikstad I, Solberg OG, Ueland T, Aukrust P, Gullestad L, SCHEDULE (SCandinavian HEart transplant everolimus De novo stUdy with earLy calcineurin inhibitors avoidancE) Investigators (2015)
The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial
Am J Transplant, 15 (7), 1967-75
DOI 10.1111/ajt.13214, PubMed 25783974

Nytrøen K, Yardley M, Rolid K, Bjørkelund E, Karason K, Wigh JP, Dall CH, Arora S, Aakhus S, Lunde K, Solberg OG, Gustafsson F, Prescott EI, Gullestad L (2015)
Design and rationale of the HITTS randomized controlled trial: Effect of High-intensity Interval Training in de novo Heart Transplant Recipients in Scandinavia
Am Heart J, 172, 96-105
DOI 10.1016/j.ahj.2015.10.011, PubMed 26856221

Publications 2014

Solberg OG, Ragnarsson A, Kvarsnes A, Endresen K, Kongsgard E, Aakhus S, Gullestad L, Stavem K, Aaberge L (2014)
Reference interval for the index of coronary microvascular resistance
EuroIntervention, 9 (9), 69-75
DOI 10.4244/EIJV919A181

Solberg OG, Ragnarsson A, Kvarsnes A, Endresen K, Kongsgård E, Aakhus S, Gullestad L, Stavem K, Aaberge L (2014)
Reference interval for the index of coronary microvascular resistance
EuroIntervention, 9 (9), 1069-75
DOI 10.4244/EIJV9I9A181, PubMed 24457279

Publications 2012

Askevold ET, Gullestad L, Aakhus S, Ranheim T, Tønnessen T, Solberg OG, Aukrust P, Ueland T (2012)
Secreted Wnt modulators in symptomatic aortic stenosis
J Am Heart Assoc, 1 (6), e002261
DOI 10.1161/JAHA.112.002261, PubMed 23316316

Solberg OG, Ueland T, Wergeland R, Dahl CP, Aakhus S, Aukrust P, Gullestad L (2012)
High-sensitive troponin T and N-terminal-brain-natriuretic-peptide predict outcome in symptomatic aortic stenosis
Scand Cardiovasc J, 46 (5), 278-85
DOI 10.3109/14017431.2012.687836, PubMed 22545649

Publications 2011

Andreassen AK, Gude E, Solberg OG, Ueland T (2011)
[Treatment of idiopathic pulmonary arterial hypertension]
Tidsskr Nor Laegeforen, 131 (13-14), 1285-8
DOI 10.4045/tidsskr.10.0053, PubMed 21725387

Ueland T, Aukrust P, Dahl CP, Husebye T, Solberg OG, Tønnessen T, Aakhus S, Gullestad L (2011)
Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis
J Intern Med, 270 (5), 452-60
DOI 10.1111/j.1365-2796.2011.02393.x, PubMed 21623962

Publications 2010

Ueland T, Gullestad L, Dahl CP, Aukrust P, Aakhus S, Solberg OG, Vermeer C, Schurgers LJ (2010)
Undercarboxylated matrix Gla protein is associated with indices of heart failure and mortality in symptomatic aortic stenosis
J Intern Med, 268 (5), 483-92
DOI 10.1111/j.1365-2796.2010.02264.x, PubMed 20804515

Publications 2007

Solberg OG, Dahl M, Mowinckel P, Stavem K (2007)
Derivation and validation of a simple risk score for predicting 1-year mortality in stroke
J Neurol, 254 (10), 1376-83
DOI 10.1007/s00415-007-0555-2, PubMed 17934885

Solberg OG, Omland T (2007)
[Arginine vasopressin antagonism--new treatment option in chronic heart failure]
Tidsskr Nor Laegeforen, 127 (2), 179-82
PubMed 17237865

Publications 2005

Solberg OG, Blom GP, Stavem K (2005)
[A patient with pulmonary metastasis of phyllodes tumour of the breast]
Tidsskr Nor Laegeforen, 125 (21), 2956-7
PubMed 16299881

Page visits: 267